Pharmaceutical products › Medicaments consisting of mixed or unmixed products for therapeutic or…
Other anesthetics
HS 300490United States → Taiwan
1Overview
- Destination duty: 0%–20% (Column 1) — calculator uses 30049010107 at 0% — No preferential agreement with United States — the basic / MFN rate applies.The rate differs between the tariff lines under this HS6. Re-check once the line is fixed.
- Business tax (營業稅): 5%
- This code covers: Other anesthetics
- Regime to watch: Taiwan express low-value exemption and frequency capExpress consignments up to NT$2,000 are duty free, but a consignee exceeding six such entries in a half-year loses the exemption and moves to a formal declaration.web.customs.gov.tw
Key points
- De minimis: a consignment with a dutiable value of NT$2,000 or less is free of duty, business tax and commodity tax. More than six such exempt releases by the same taxpayer in a half-year makes them a frequent importer, and the exemption stops.
- Business tax is 5%, collected by customs. A trade promotion service fee of 0.04% also applies, plus commodity tax on listed categories and tobacco and alcohol tax.
- Using a customs broker is not mandatory; the taxpayer may file directly, but the declaration still goes through the Single Window electronically.
- Express consignments are graded by dutiable value: X1 (documents), X2 (NT$2,000 or less, exempt), X3 (NT$2,001 to 50,000, dutiable) and X4 (over NT$50,000, which requires a full import declaration).
- Before importing from mainland China, check the import-rule column for MW0 (not permitted) or MP1 (permitted with conditions). For express consignments addressed to an individual, the declaration is only accepted once the consignee has completed real-name verification in the EZ WAY app.
Key points on the origin side
- No export duty and no export VAT refund, because the United States has no VAT.
- EEI must be filed in AESDirect when any single Schedule B or HTS line in the shipment exceeds US$2,500, or when a licence is required at any value; the ITN returned by AES must reach the carrier before lading.
- Classify with Schedule B for the declaration, and determine the ECCN for anything that may be controlled under the EAR.
- Screen all parties against the OFAC Specially Designated Nationals list and the BIS Entity List and Denied Persons List before shipping.
- Export records are generally kept for five years from the date of export under 15 CFR 30.10.
As of: 2026-07-29 · Guidance as of: 2026-09
2Classification
HS6 names
- ko기타
- enOther anesthetics
- zh_hant其他麻醉劑
- zh_hans其他麻醉剂
Taiwan tariff lines
| Line | Description |
|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類)Medicaments,containing thiamylal,5-allyl-5-(1-methylbutyl)-2-thiobarbiturates, including: Isomers, Esters, Ethers, Salts |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Ketamine , and its isomer, esters, ethers, salts |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者Medicaments, containing Propofol , Etomidate, and their isomer, esters, ethers, salts |
| 30049010900 | 其他麻醉劑Other anesthetics |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations of gennetic recombinants |
| 30049030005 | 營養與電解質液Nutrients and electrolytes |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者Hemodialysis concentrate, put up in measured doses or in forms or packings for retail sale |
| 30049050000 | 磺胺藥Antibacterial, sulfa drugs |
| 30049061007 | 中藥酒劑Chinese medicine wine |
| 30049069009 | 其他中藥製劑Other chinese medicine preparations |
| 30049071005 | 抗癌藥Anti-cancer preparations |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections |
| 30049080004 | 農藥中毒解毒劑Pesticide-poisoning cures |
| 30049091001 | 抗排斥醫藥製劑Immunosuppressive preparations |
| 30049092000 | 安瓿裝蒸餾水Water, distilled, in ampoules |
| 30049099101 | 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine |
| 30049099218 | 醫藥製劑,含有西可巴比妥者Medicaments, containing secobarbital |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者Medicaments, containing amobarbital |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者Medicaments, containing Triazolam |
| 30049099325 | 醫藥製劑,含有氟硝西泮者Medicaments, containing Flunitrazepam |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者Medicaments, containing Lormetazepam |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者Medicaments, containing Fludiazepam |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者Medicaments, containing Estazolam |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者Medicaments, containing Alprazolam |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者Medicaments, containing Temazepam |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者Medicaments, containing Midazolam |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者Medicaments, containing Tramadol |
| 30049099423 | 醫藥製劑,含有伯替唑他者Medicaments, containing Brotizolam |
| 30049099432 | 醫藥製劑,含有唑匹可隆者Medicaments, containing Zopiclone |
| 30049099441 | 玻璃體替代物Viscoelastic material for ophthalmic surgery |
| 30049099450 | 醫藥製劑,含有札來普隆者Medicaments, containing Zaleplon |
| 30049099469 | 醫藥製劑,含有佐沛眠者Medicaments, containing Zolpidem |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Remifentanil, and its isomer, esters, ethers, salts |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Alfentanyl , and its isomer, esters, ethers, salts |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Fentanyl , and its isomer, esters, ethers, salts |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者Medicaments, containing Methadone , and its isomer, esters, ethers, salts |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentazocine , and its isomer, esters, ethers, salts |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Sufentanil , and its isomer, esters, ethers, salts |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者Medicaments, containing Tetrahydrocannabinols, and its isomer, esters, ethers, salts |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者Medicaments, containing Methylphenidate , and its isomer, esters, ethers, salts |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者Medicaments, containing Tapentadol, and its isomers, esters, ethers, salts |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentobarbital(excluding amobarbital), and its isomer, esters, ethers, salts |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nimetazepam , and its isomer, esters, ethers, salts |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者Medicaments, containing Barbital , and its isomer, esters, ethers, salts |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Bromazepam , and its isomer, esters, ethers, salts |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Lorazepam , and its isomer, esters, ethers, salts |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Medazepam , and its isomer, esters, ethers, salts |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者Medicaments, containing Meprobamate , and its isomer, esters, ethers, salts |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nitrazepam , and its isomer, esters, ethers, salts |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nordazepam , and its isomer, esters, ethers, salts |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazepam , and its isomer, esters, ethers, salts |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazolam , and its isomer, esters, ethers, salts |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pemoline , and its isomer, esters, ethers, salts |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing clobazam , and its isomer, esters, ethers, salts |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clonazepam , and its isomer, esters, ethers, salts |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clorazepate , and its isomer, esters, ethers, salts |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Cloxazolam , and its isomer, esters, ethers, salts |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Diazepam , and its isomer, esters, ethers, salts |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者Medicaments, containing Flurazepam , and its isomer, esters, ethers, salts |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Prazepam , and its isomer, esters, ethers, salts |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者Medicaments, containing Modafinil , and its isomer, esters, ethers, salts |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者Medicaments, containing Butorphanol , and its isomer, esters, ethers, salts |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者Medicaments, containing Clobenzorex , and its isomer, esters, ethers, salts |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Lisdexamphetamine , and its isomer, esters, ethers, salts |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale |
United States export-side line (reference)
- 3004.90.10.00Containing antigens or hyaluronic acid or its sodium salt
- 3004.90.92Other
- 3004.90.92.01For veterinary use
- 3004.90.92.03Containing acyclovir or its salts
- 3004.90.92.04Containing oseltamivir or its salts
- 3004.90.92.05Containing valganciclovir, peramivir or their salts
- 3004.90.92.06Other
- 3004.90.92.07Containing fluconazole or its salts
- 3004.90.92.08Other
- 3004.90.92.09Containing metronidazole or its salts
- 3004.90.92.10Other
- 3004.90.92.11Containing trimethoprim and sulfamethoxazole or their salts
- 3004.90.92.12Other
- 3004.90.92.13Containing levofloxacin or its salts
- 3004.90.92.14Containing linezolid or its salts
- 3004.90.92.15Other
- 3004.90.92.16Containing hydroxyurea or cyclophosphamide or their salts
- 3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its salts
- 3004.90.92.18Other
- 3004.90.92.19Containing metoprolol or its salts
- 3004.90.92.20Containing amiodarone or its salts
- 3004.90.92.21Containing diltiazem or its salts
- 3004.90.92.22Containing hydralazine or its salts
- 3004.90.92.23Containing enoxaparin or its salts
- 3004.90.92.24Containing labetalol or its salts
- 3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts
- 3004.90.92.26Other
- 3004.90.92.27Tolmetin
- 3004.90.92.28Tolmetin sodium dihydrate
- 3004.90.92.29Tolmetin sodium (anhydrous)
- 3004.90.92.30For oral suspension
- 3004.90.92.31Other
- 3004.90.92.32For oral suspension
- 3004.90.92.33Other
- 3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)
- 3004.90.92.35Containing tramadol
- 3004.90.92.36Other
- 3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their salts
- 3004.90.92.38Containing midazolam or its salts
- 3004.90.92.39Containing phenytoin or its salts
- 3004.90.92.40Containing propofol or its salts
- 3004.90.92.41Containing levetiracetam, phenytoin or their salts
- 3004.90.92.42Containing etomidate or its salts
- 3004.90.92.43Other
- 3004.90.92.44Containing lorazepam or its salts
- 3004.90.92.45Containing olanzapine or its salts
- 3004.90.92.46Other
- 3004.90.92.47Containing rocuronium or its salts
- 3004.90.92.48Containing succinylcholine or its salts
- 3004.90.92.49Other
- 3004.90.92.50Containing lidocaine or its salts
- 3004.90.92.51Other
- 3004.90.92.52Laxatives
- 3004.90.92.53Antacids
- 3004.90.92.54Containing famotidine or its salts
- 3004.90.92.55Containing pantoprazole or its salts
- 3004.90.92.56Containing ondansetron or its salts
- 3004.90.92.57Containing glycopyrrolate or its salts
- 3004.90.92.58Containing loperamide or its salts
- 3004.90.92.60Other
- 3004.90.92.61Containing furosemide and its salts
- 3004.90.92.62Containing hydrochlorothiazide or its salts
- 3004.90.92.63Other
- 3004.90.92.64Containing calcium gluconate
- 3004.90.92.65Containing potassium chloride
- 3004.90.92.66Containing sodium bicarbonate, in injection form
- 3004.90.92.67Other
- 3004.90.92.68Cough and cold preparations
- 3004.90.92.69Containing diphenhydramine or its salts
- 3004.90.92.70Other
- 3004.90.92.71Containing albuterol sulfate
- 3004.90.92.72Containing timolol maleate
- 3004.90.92.73Other
- 3004.90.92.74Containing heparin sodium or its salts
- 3004.90.92.75Containing zoledronic acid or its salts
- 3004.90.92.76Other
Top 3 Taiwan rulings
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)
As of: 2026-07-29
3Duty & tax
No preferential agreement with United States — the basic / MFN rate applies.
| Line | Description | Column 1 | Column 2 | Column 3 |
|---|---|---|---|---|
| 30049010107 | 醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類) | 0% | 0% | 0% |
| 30049010205 | 醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010303 | 醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 0% |
| 30049010900 | 其他麻醉劑 | 0% | 0% | 0% |
| 30049020007 | 血液代用品與血漿代用品及基因重組製劑 | 0% | 0% | 0% |
| 30049030005 | 營養與電解質液 | 0% | 0% | 10% |
| 30049040003 | 洗腎用清洗液,具有劑量或零售包裝式樣者 | 0% | 0% | 10% |
| 30049050000 | 磺胺藥 | 0% | 0% | 20% |
| 30049061007 | 中藥酒劑 | 20% | 0% | 50% |
| 30049069009 | 其他中藥製劑 | 0% | 0% | 12.5% |
| 30049071005 | 抗癌藥 | 0% | 0% | 0% |
| 30049072004 | 抗人類免疫缺乏病毒感染用藥 | 0% | 0% | 10% |
| 30049080004 | 農藥中毒解毒劑 | 0% | 0% | 0% |
| 30049091001 | 抗排斥醫藥製劑 | 0% | 0% | 10% |
| 30049092000 | 安瓿裝蒸餾水 | 0% | 0% | 10% |
| 30049099101 | 抗過敏抗組織胺用藥 | 0% | 0% | 10% |
| 30049099218 | 醫藥製劑,含有西可巴比妥者 | 0% | 0% | 10% |
| 30049099227 | 醫藥製劑,含有異戊巴比妥者 | 0% | 0% | 10% |
| 30049099316 | 醫藥製劑,含有三唑他(三唑侖)者 | 0% | 0% | 10% |
| 30049099325 | 醫藥製劑,含有氟硝西泮者 | 0% | 0% | 10% |
| 30049099334 | 醫藥製劑,含有氯甲西泮(甲基樂耐平)者 | 0% | 0% | 10% |
| 30049099343 | 醫藥製劑,含有氟地西泮(氟二氮平)者 | 0% | 0% | 10% |
| 30049099352 | 醫藥製劑,含有舒樂安定(伊疊唑侖)者 | 0% | 0% | 10% |
| 30049099361 | 醫藥製劑,含有阿普唑他(三氮二氮平)者 | 0% | 0% | 10% |
| 30049099370 | 醫藥製劑,含有替馬西泮(甲羥氮平)者 | 0% | 0% | 10% |
| 30049099389 | 醫藥製劑,含有咪達唑他(咪氟唑侖)者 | 0% | 0% | 10% |
| 30049099414 | 醫藥製劑,含有特拉嗎竇者 | 0% | 0% | 10% |
| 30049099423 | 醫藥製劑,含有伯替唑他者 | 0% | 0% | 10% |
| 30049099432 | 醫藥製劑,含有唑匹可隆者 | 0% | 0% | 10% |
| 30049099441 | 玻璃體替代物 | 0% | 0% | 10% |
| 30049099450 | 醫藥製劑,含有札來普隆者 | 0% | 0% | 10% |
| 30049099469 | 醫藥製劑,含有佐沛眠者 | 0% | 0% | 10% |
| 30049099520 | 醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099539 | 醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099548 | 醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099557 | 醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099566 | 醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099575 | 醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099584 | 醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099593 | 醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099619 | 醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099628 | 醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099637 | 醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099646 | 醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099655 | 醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099664 | 醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099673 | 醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099682 | 醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099691 | 醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099717 | 醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099726 | 醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099735 | 醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099744 | 醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099753 | 醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099762 | 醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099771 | 醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099780 | 醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099799 | 醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099815 | 醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099824 | 醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099833 | 醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099842 | 醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099851 | 醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099860 | 醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者 | 0% | 0% | 10% |
| 30049099904 | 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者 | 0% | 0% | 10% |
Destination costs beyond the duty (internal taxes and fees)
about +5.04% beyond the dutyWhat the destination customs authority collects alongside the duty. Every line carries its base formula, legal basis, as-of date and source.
| Item | Rate | Legal basis | As of · source |
|---|---|---|---|
| Trade-promotion service fee 0.04%0.04% of (customs value (CIF)); not collected where the amount payable is 100 TWD or less. | 0.04% | 貿易法 第21條之1 · 貿易法施行細則 第17條 · 推廣貿易服務費免收項目範圍(2024-02-02) | As of: 2026-09經濟部國際貿易署 — 推廣貿易服務費 |
| Business tax (營業稅)5% of (customs value (CIF) + duty). | 5% | 加值型及非加值型營業稅法 第41條 | As of: 2026-09財政部關務署 — 海關如何課徵進口貨物營業稅? |
Caveats
- Trade-promotion service fee 0.04% is not collected where the amount payable is 100 TWD or less. The calculator does not apply that floor, because it does not know which currency you typed.
- Excise and requirement lists are written at the national tariff line, not at HS6. An HS6 code can only give the general picture.
- A small or personal consignment may go through a different regime with a different tax result — see the routes listed below.
- De minimis: NT$2,000 per-consignment exemption.
- Information only, as of 2026-09-09. The rates and the customs value fixed on the entry date control — verify with the customs authority or a licensed broker.
De minimis
NT$2,000 per-consignment exemption
A consignment with a dutiable value of NT$2,000 or less is free of customs duty, business tax and commodity tax. The trade-promotion fee is in practice not collected in this range either, because of its NT$100 floor.
· More than six such duty-free releases by the same taxpayer within a half-year (Jan–Jun / Jul–Dec) triggers a 頻繁進口 designation and the exemption is withdrawn.
· Alcohol, tobacco and tariff-quota agricultural products are excluded regardless of value.
- Threshold:
- 2000 TWD
- Legal basis:
- 關稅法 第49條
Other clearance routes (3)
- X2 low-value duty-free express consignment (≤ NT$2,000)effective rate about 0%duty 0%
Cleared on a simplified declaration with no tax charged. Only the C1 (no review, no inspection) or C3 (physical inspection) channels are assigned.
- Applies when:
- Air express consignment with a dutiable value of NT$2,000 or less
- Limits:
- 2000 TWD/shipment
- X3 low-value dutiable express consignment (NT$2,001–50,000)
Cleared on a simplified declaration, but duty and business tax are charged normally. Goods subject to import controls, drawback, quota, special duties or the special-goods tax must use a full 進口報單.
- Applies when:
- Air express consignment with a dutiable value between NT$2,001 and NT$50,000
- Limits:
- 2001 TWD/shipment · 50000 TWD/shipment
- EZ WAY real-name verification — required for individual consignees
An import express consignment addressed to an individual is only accepted for declaration once the consignee has completed real-name verification in the EZ WAY app, binding a mobile number to an ID or residence-permit number. Without it clearance is held until corrected. Basis: 空運快遞貨物通關辦法 §17(3); enforced in the clearance system since 2020-05-16.
- Applies when:
- Any import express consignment addressed to an individual
Information, not advice. What is actually charged is fixed by Customs on the dutiable value and the rates in force on the entry date. 貨物稅 and 菸酒稅 fall only on goods listed in their statutes, which an HS6 code cannot settle. Verify with the Customs Administration or a licensed 報關業者.
As of: 2026-09-09
- · Business tax = (dutiable value + import duty + commodity tax or tobacco and alcohol tax + tobacco health and welfare surcharge) x 5%, collected by customs under Article 41 of the Business Tax Act.
- · Trade promotion service fee: 0.04% (four per ten thousand) of the customs value, under art. 21-1 of the Foreign Trade Act and art. 17 of its enforcement rules; it is not collected where the amount payable is NT$100 or less.
- · Commodity tax applies only to the categories listed in the Commodity Tax Act, such as electrical appliances, vehicles, oil and gas, cement, beverages, flat glass and rubber tyres; the base is the dutiable value plus import duty.
- · Tobacco and alcohol tax: for example NT$1,590 per 1,000 cigarettes, NT$26 per litre of beer, and NT$2.5 per litre per degree of alcohol for distilled spirits; tobacco also carries a health and welfare surcharge of NT$1,000 per 1,000 cigarettes.
- · Special goods and services tax of 10% applies to passenger cars, aircraft, yachts and high-value goods above set thresholds.
Landed-cost estimate
- Duty rate used(0%–20%)
- 0%
- Customs value
- —
- Duty
- —
- Trade-promotion service fee 0.04% (0.04%)
- —
- Business tax (營業稅)
- —
- Estimated total
- —
A rough estimate. The real amount depends on valuation, classification and origin determination.
The rate differs between the tariff lines under this HS6. Re-check once the line is fixed. calculator uses 30049010107 at 0%
As of: 2026-07-29
4Requirements
- 503Importation of drugs (including pharmaceutical products, active pharmaceutical ingredients, diagnostics and biological products) for human use requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Ministry of Health and Welfa…
- 5041. Importation of medical devices for human use must be handled according to the following regulations: (1) A photocopy of the medical devices pre-marketing license or an approval document issued by the Ministry of Health and Welfare should be submitted. In addition, the number of the pre-marketing license (consisting of 14 letters and digits) must be declared and listed in the import declaration…
- 505Importation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Department of Chinese Medicine and Pharmacy, Ministry…
- 522For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs
- 802(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.
- 804(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…
- 814(1) Importation of traditional chinese drugs for human use is governed by the regulation of "505". (2) Importation of veterinary chinese medicines is governed by the regulation of "406".(3) For importing good under this item without import approval document from the competent authority, is not allowed to be imported.
- MP1(1) Importation of Mainland China products in this category is conditionally permitted. The importation should conform to the regulations of "Consolidated List of Conditional Import Items of Mainland China Origin and Regulations Governing Import of Mainland China Origin Commodities".(2) Importation of items on the "Consolidated List of Conditional Import Items of Mainland China Origin and Regulat…
- MW0Importation of Mainland China products is prohibited.
Agencies involved
- Customs Administration, Ministry of FinanceImport clearance, tariff classification, valuation, and collection of business tax and commodity taxweb.customs.gov.tw
- Customs-Port-Trade Single WindowElectronic platform for import and export declarations, import regulation lookup and paymentportal.sw.nat.gov.tw
- International Trade Administration, Ministry of Economic AffairsImport and export regulations, import permits, control of mainland Chinese goods (MW0 / MP1)trade.gov.tw
- Bureau of Standards, Metrology and Inspection (BSMI)Inspection and certification of listed commodities and product safety markingbsmi.gov.tw
- Taiwan Food and Drug Administration (TFDA)Border inspection of imported food, cosmetic product listing and product information filesfda.gov.tw
- Animal and Plant Health Inspection Agency, Ministry of AgricultureQuarantine of imported animals, plants and their productsaphia.gov.tw
As of: 2026-08-27
5Documents
United States export documents
- Commercial invoice
- Issued by:
- Exporter
- When:
- With the shipment
Buyer, seller, description, quantity, value, currency, terms of sale and country of origin; used by the destination customs authority as well.
Official page - Packing list
- Issued by:
- Exporter
- When:
- With the shipment
Carton-level contents, weights, dimensions and marks.
Official page - Bill of lading or air waybill
- Issued by:
- Carrier or freight forwarder
- When:
- Issued at loading
Contract of carriage; the ocean bill of lading is also the document of title.
Official page - Electronic Export Information (EEI) and ITN
- Issued by:
- Exporter or authorised agent, filed in AESDirect within ACE
- When:
- Before lading, on the deadline for the mode of transport
Required when a single Schedule B or HTS line exceeds US$2,500 or a licence is required. The ITN is the proof of filing.
Official page - Shipper's Letter of Instruction (SLI)
- Issued by:
- Exporter
- When:
- When a forwarder files on the exporter's behalf
Authorises the forwarder as agent and carries the data needed for the AES filing.
Official page - Export licence
- Issued by:
- Bureau of Industry and Security (EAR) or Directorate of Defense Trade Controls (ITAR)
- When:
- Before export, when the ECCN or USML category and destination require it
Licence exceptions may be available; the licence or exception is cited in the AES filing.
Official page - Certification of origin for a free trade agreement
- Issued by:
- Exporter or producer
- When:
- Provided to the buyer for its import claim
KORUS uses self-certification with no prescribed form. There is no agreement covering Taiwan or mainland China.
Official page - Certificate of Free Sale or FDA export certificate
- Issued by:
- U.S. Food and Drug Administration or a state authority
- When:
- When the importing country's authority asks for it
Common for food, dietary supplements, cosmetics, drugs and medical devices going to Korea, Taiwan or mainland China.
Official page - Power of attorney to the forwarder
- Issued by:
- Exporter
- When:
- Before the forwarder acts
Needed for the forwarder to file EEI and act before CBP as authorised agent.
Official page
Taiwan import documents
- Import declaration (進口報單)
- Issued by:
- Customs broker or importer, transmitted through the Single Window
- When:
- Within 15 days from the day after the conveyance's import date
Low-value express consignments may instead use a simplified declaration (X1 to X3). Goods subject to an import regulation, drawback, quota, special duties or the special goods and services tax must use a full import declaration.
Official page - Delivery order (小提單, D/O)
- Issued by:
- Carrier or freight forwarder
- When:
- Exchanged after the goods arrive
The document against which the goods are collected from the container terminal or warehouse.
Official page - Commercial invoice
- Issued by:
- Exporter
- When:
- With the declaration
The primary basis for the dutiable value; it should state description, quantity, unit price, terms of sale and country of origin.
Official page - Packing list
- Issued by:
- Exporter
- When:
- With the declaration
Used for reconciliation during a C3 physical examination.
Official page - Bill of lading or air waybill
- Issued by:
- Carrier
- When:
- Issued at loading
Reconciled against the manifest and used to obtain the delivery order.
Official page - Certificate of origin
- Issued by:
- Issuing body in the exporting country
- When:
- When claiming a preferential rate or when the import regulation requires it
Goods on the ECFA early harvest list imported from mainland China need an ECFA certificate of origin to obtain the preferential rate.
Official page - Import permit
- Issued by:
- International Trade Administration or another competent authority
- When:
- When the import regulation column shows a corresponding code
Goods with no code are generally free of permit requirements; codes such as MW0 and MP1 relate to the control of mainland Chinese goods.
Official page - Power of attorney (委任書)
- Issued by:
- Importer (taxpayer)
- When:
- Before appointing a customs broker
Authorises the broker to declare, pay the taxes and collect the goods.
Official page - Inspection and border-check documents
- Issued by:
- BSMI, TFDA
- When:
- With or before the declaration
Inspection pass for goods on the BSMI list; import inspection application for food; cosmetic product listing and the product information file (PIF).
Official page
6Procedure
- Advance cargo data and storageThe carrier transmits the manifest, and after discharge the goods enter a container terminal, wharf or bonded warehouse.
- Delivery order and documentsExchange the bill of lading for a delivery order and assemble the invoice, packing list, certificate of origin and any import permit.
- File the import declarationThe broker or the importer transmits the import declaration through the Single Window, within 15 days from the day after the conveyance's import date.
- Clearance channelThe system assigns C1 (release without review), C2 (document review) or C3 (physical examination, either manual C3M or scanned C3X). Goods requiring inspection wait for the competent authority's result.
- Pay duty and taxesPay the import duty, business tax, commodity tax where applicable and the trade promotion service fee. Online payment is available, as is release before payment where the rules allow it.
- Release and collectionAfter the release notice the goods are collected from the terminal. Amendment, refund and post-clearance audit procedures follow separately.
- Manifest and storageThe airline transmits the manifest and the goods enter the air cargo terminal.
- Documents and declarationAssemble the documents and transmit the import declaration through the Single Window; the same 15-day deadline applies.
- Channel and examinationThe declaration is routed C1, C2 or C3. Goods regulated by BSMI or TFDA must complete their inspection procedure.
- PaymentPay the duty, business tax and related fees.
- ReleaseCollect the goods from the air cargo terminal.
- Express categoriesExpress consignments are graded by customs value into X1 (import express documents), X2 (low-value duty-free, NT$2,000 or less), X3 (low-value dutiable, NT$2,001–50,000) and X4 (high-value, over NT$50,000). X1 to X3 are assigned only the C1 (release) or C3 (examination) channel; X4 can be assigned C1, C2 or C3.
- Simplified or full declarationX1 to X3 may use a simplified declaration. X4, and anything involving an import regulation, drawback, quota, special duties or the special goods and services tax, requires a full import declaration.
- Exemption and frequent-importer testA dutiable value of NT$2,000 or less is exempt, but more than six exempt releases by the same taxpayer within a half-year ends the exemption. Tobacco, alcohol and tariff-quota agricultural products never qualify.
- PaymentWhere tax is due, the express operator normally pays and recovers it from the consignee, or the consignee pays directly.
- Goods subject to inspectionElectrical goods and other items on the BSMI inspection list bought online still need inspection or an inspection waiver; without it they are not released and a penalty may follow.
- Consignee real-name verification (EZ WAY)For an import express consignment addressed to an individual, art. 17(3) of the Regulations Governing Customs Clearance for Air Express Consignments requires the consignee to complete real-name verification in the EZ WAY app, binding a mobile number to an ID or residence-permit number. Customs has checked the express-consignment declaration authorisation in its clearance system since 2020-05-16; where the importer is not verified, the declaration is not accepted until the omission is corrected.
- Declaration on arrivalTravellers carrying dutiable or declarable goods use the red channel and complete a declaration form.
- AllowanceFor an adult traveller, personal and household articles are exempt up to a total customs value of NT$35,000, raised from NT$20,000 with effect from 2024-06-26. Separately, 1.5 litres of alcohol (any number of bottles, travellers 18 and over), and 200 cigarettes or 25 cigars or one pound of tobacco (travellers 20 and over) are exempt; articles the traveller already owned and used abroad are exempt separately where a single article or set has a customs value of NT$10,000 or less. The NT$35,000 exemption does not apply to travellers who are evidently carrying goods for profit or who travel frequently — twice or more within 30 days, or six times or more within half a year. The basis is art. 11 of the Regulations Governing the Inspection, Taxation and Release of Inbound Passengers' Baggage.
- Commercial goodsGoods that are not for personal use follow the ordinary import procedure even when hand-carried, and must meet the import regulation and inspection requirements.
- PaymentAnything above the allowance is valued by customs on arrival and the tax is paid on the spot.
Show United States export-side steps
- Classify and screenDetermine the Schedule B number, check whether the item has an ECCN on the Commerce Control List or falls under the USML, and screen the buyer, end user and end use against the OFAC and BIS lists.
- Book and documentBook with the carrier or forwarder, and prepare the commercial invoice, packing list and Shipper's Letter of Instruction. Obtain any export licence that applies.
- File EEIFile the EEI in AESDirect at least 24 hours before the cargo is loaded onto the vessel, and record the ITN returned by the system.
- Deliver and ladeDeliver the cargo to the terminal. The carrier cites the ITN on its outbound manifest; without it the goods should not be laded.
- Departure and documentsAfter sailing, collect the bill of lading and send the shipping documents and the origin certification to the buyer for its import clearance.
- RecordkeepingKeep the export records, generally for five years from the date of export, and correct the AES filing if the shipment particulars change.
7Difficulty
Score: 0.87
A signal derived from public data, not advice.
Why this reading
- regime[TFDA] 藥事法 — 藥商許可執照 + 藥品許可證Medicines need a pharmaceutical-firm licence and a per-product marketing licence; even personal-use import is quantity-capped.fda.gov.tw2026-09-07
- requirement6 destination import requirement(s) found: For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an ap, (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of co, Importation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the dru, and 3 moreportal.sw.nat.gov.tw2026-09-07
- ambiguityClassification is contested — 17 TW rulings split across 2 subheadings.web.customs.gov.tw2026-09-07
Components
| Import requirements | 0.89 | For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an ap portal.sw.nat.gov.tw(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of co portal.sw.nat.gov.twImportation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the dru portal.sw.nat.gov.tw |
|---|---|---|
| Classification ambiguity | 0.56 | TW rulings: 17, spread over 2 subheadings web.customs.gov.twUS CROSS: 1057 rulings, 21% of them decided on more than one line · 66 other HS6 codes examined in the same cases rulings.cbp.gov |
| Regulatory regime | 1.00 | 藥事法 — 藥商許可執照 + 藥品許可證 fda.gov.tw |
As of: 2026-09-07
8Cases
Rulings held:Korea 197United States 1057Taiwan 17China —
Rulings from the destination authority come first, newest first. A similar case does not by itself decide the classification.
Taiwan rulings (destination)
Showing the 10 most recent of 17 held
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液-全日型加強配方(未滅菌) EXCILOR FORTE-nail solution(non-sterile)Decided line: 30049099904Date: 2021Reference: 110AA0179
- 其他中藥製劑枳椇人參茶(Gan-Pyun-Han-Nal) / 液體茶 / 100ML /瓶Decided line: 30049069009Date: 2018Reference: 107AA0256
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Hiruscar Silicone Pro(non-sterile) 喜療疤 疤痕護理矽凝膠(未滅菌)Decided line: 30049099904Date: 2018Reference: 107AA0177
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者貽貝粘蛋白創面修復敷料 型號、規格:0.5mg/mL×0.2mL、0.5mg/mL×0.5mL、0.5mg/mL×1mL、0.5mg/mL×3mL、0.5mg/mL×5mL 0.5mg/mL×10mL、0.5mg/mL×15mL、0.5mg/mL×20mL、1.5mg/mL×0.2mL、1.5mg/mL×0.5mL 1.5mg/mL×3mL、……、1.5mg/mL×20mL等(詳附件)Decided line: 30049099904Date: 2018Reference: 107AA0128
- 其他中藥製劑云南彝葯排毒眼罩Decided line: 30049069009Date: 2018Reference: 107AA0382
Show 5 more
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲筆(未滅菌) EXCILOR Nail Pen(non-sterile)Decided line: 30049099904Date: 2017Reference: 106AA0736
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者恢甲清覆甲液(未滅菌) EXCILOR Nail Solution(non-sterile)Decided line: 30049099904Date: 2017Reference: 106AA0735
- 其他中藥製劑黃金紅蔘精/液體(茶)食品/Net wt. 250g/真空玻璃瓶Decided line: 30049069009Date: 2017Reference: 106AA0411
- 其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者品名:通用名:骨修復材料 商標名:骨優導 / 型號規格:1mg rhBMP-2/BottleDecided line: 30049099904Date: 2017Reference: 106CA0111
- 其他中藥製劑韓國護肝寶 HD-1 PremiumDecided line: 30049069009Date: 2017Reference: 106AA0182
United States rulings (origin)
Showing the 10 most recent of 1057 held
- NYThe tariff classification of Pantoprazole Sodium Tablets in dosage form, from IndiaDecided line: 3004.90.9255Date: 2026-07-14Reference: N362421
- NYThe tariff classification of Tadalafil Tablets in dosage form, from IndiaDecided line: 3004.90.9276Date: 2026-06-25Reference: N361847
- NYThe tariff classification of Nintedanib Capsules in dosage form, from IndiaDecided line: 3004.90.9216Date: 2026-05-26Reference: N361639
- NYThe tariff classification of Brivaracetam Oral Solution in dosage form, from IndiaDecided line: 3004.90.9243Date: 2026-05-06Reference: N360453
- NYThe tariff classification of Colestipol Hydrochloride Tablets in dosage form, from TaiwanDecided line: 3004.90.9225Date: 2026-05-06Reference: N360493
Show 5 more
- NYThe tariff classification of Sugammadex Injection in dosage form, from IndiaDecided line: 3004.90.9276Date: 2026-04-29Reference: N360371
- NYThe tariff classification of Brimonidine Tartrate and Timolol Maleate Ophthalmic Drops 0.2%/0.5% in dosage form, from IndiaDecided line: 3004.90.9272Date: 2026-04-28Reference: N360180
- NYThe tariff classification of Bumetanide Tablets in dosage form, from IndiaDecided line: 3004.90.9263Date: 2026-04-28Reference: N360214
- NYThe tariff classification of Bumetanide Tablets in dosage form, from ItalyDecided line: 3004.90.9263Date: 2026-04-28Reference: N360217
- NYThe tariff classification of Bumetanide Tablets in dosage form, from SpainDecided line: 3004.90.9263Date: 2026-04-28Reference: N360218
Show rulings from other countries (15)
- KR관세평가분류원ㅇ 재우스오라쿠고에이취플라스타(살리실산); OLAKUKO - H;ㅇ 물품개요 - 살리실산을 주성분으로 한 황색 페이스트를 원형 스펀지 중앙에 채운 후 스트립상의 접착시트에 부착한 것을 소매포장한 것(내용량 : 100g, 12매/box) - 용도: 티눈, 굳은 살, 사마귀 제거(일반의약품)Decided line: 3004909900Date: 2026-02-12Reference: CLIP-0072026000156
- KR관세평가분류원Medicaments; 재우스오라쿠고에이취플라스타(살리실산)- 살리실산을 주성분으로 한 황색 페이스트를 원형 스펀지 중앙에 채운 후 스트립상의 접착시트에 부착한 것을 지제상자에 소매포장한 것(내용량 : 100g, 12매/box) - 용도 : 일반의약품(티눈, 굳은 살, 사마귀 제거) ※ 품목분류는 수출입신고 당시의 물품 상태에 따라 변경될 수 있음Decided line: 3004909900Date: 2025-11-11Reference: CLIP-0072025004895
- KR관세평가분류원POSSㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...Decided line: 3004909900Date: 2024-03-11Reference: CLIP-0072023004368
- KR관세평가분류원S1ㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...Decided line: 3004909900Date: 2024-03-11Reference: CLIP-0072023004366
- KR관세평가분류원BOSSㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...Decided line: 3004909900Date: 2024-03-11Reference: CLIP-0072023004367
- KR관세평가분류원Medicaments; DIABEX XR 500mg메트포르민염산염, 미결정셀룰로오스, 스테아르산 마그네슘, 카르복시메틸셀룰로오스나트륨, 히프로멜로오스, 정제수를 혼합하여 조제한 백색 타원형 정제를 수지제 블라스터 포장한 것을 종이제 상자에 소매포장한 것(내용량: 15 x 4ea/60정) - 용도: 경구용 혈당 강하제 ※ 품목분류는 수출입신고 당시의 물품상태에...Decided line: 3004909900Date: 2023-07-14Reference: CLIP-0072023002558
- KR관세평가분류원INVISIBLE MASKㅇ 물품개요 - Hydroxypropyl methylcellulose 95%에 레몬향 분말을 혼합·조제한 백색계 분말을 플라스틱 용기에 충전 후 종이상자에 소매포장한 것(내용량 : 800㎎) - 작용 : 비강 내부에 분사하면 내용물이 비강 내의 습기와 결합하여 겔(gel)형태로 변하여 내부를 피복함 - 기능 ...Decided line: 3004909900Date: 2023-03-27Reference: CLIP-0072023001085
- KR관세평가분류원Medicaments, packings for retail sale①건조 쑥분말 86%에 물 11%, 칼슘(쑥봉 타는 속도 지연), 옥수수전분(점결제)을 혼합하여 원통형으로 압축 성형 후 건조한 쑥봉에 종이재질의 원통형 지지물(지관)을 결합하고 하단에 접착스티커를 부착시킨 것 180개, ②이면지에 부착된 원형의 피부보호용 스티커(무흔지) 2장, ③제품사용설명서(주요 뜸자리)...Decided line: 3004909900Date: 2021-04-12Reference: CLIP-0072021001331
- KR관세평가분류원Medicament; Mentho Pas Lotionㅇ 살리실산메틸, L-멘톨, 리놀린유, 미네랄오일, 소르비탄스테아레이트, 정제수, 카보머941, 트롤아민, 폴리소르베이트60으로 혼합·조제된 백색계 점조액상을 플라스틱 용기에 포장 후 지제박스에 최종 소매포장(내용량 : 100ml)한 것 - 용도 : 의약품(근육통, 요통, 류마티스통증 등 환부에 바름) ※ ...Decided line: 3004909900Date: 2021-04-06Reference: CLIP-0072021001328
- KR관세평가분류원Medicaments, anti-cancer preparation TEPADINA, Thiotepaㅇ 주입용액 조제용 티오테파(Thiotepa) 백색 분말을 유리제 용기에 넣어 지제박스에 소매포장한 것(내용량: 15㎎) - 용도 : 항암제(혈액질환, 고형종양 등) ※ 품목분류는 수출입신고 당시의 물품상태에 따라 변경될 수 있음Decided line: 3004901000Date: 2020-04-02Reference: CLIP-0072020001282
- KR관세평가분류원Medicaments; 인애백년보건고; PR.CHNAㅇ쑥, 생강, 삼칠초, 홍화, 혈갈, 용뇌향을 섞어 열처리 후 농축정제한 물품에 밀랍 68%를 혼합하여 고체상태로 만들어 소매포장(1,000g/통)한 것 - 용도 : 찜질용(목, 어깨, 허리, 무릎 등 피로로 인하여 불편한 부위 완화)Decided line: 3004909900Date: 2019-08-16Reference: CLIP-0072019003378
- KR관세평가분류원Medicaments; FD; MEXICOLidocaine hydrochloride(2 %), Epinephrine(0.001 %), Sodium chloride, Water 등으로 조성된 무색 투명 액상의 주사액을 플라스틱제 앰플에 소매포장한 것(1.8 ml x 10 cartridges) - 용도: 치과용 국소마취제Decided line: 3004909900Date: 2018-11-19Reference: CLIP-0072018005196
- KR관세평가분류원Medicaments; Turbocaina; MEXICOㅇArticaine hydrochloride(4%), Epinephrine(0.001%), Sodium chloride, Water 등으로 조성된 국부마취제 성분의 주사액를 주입한 유리제 앰플을 소매포장한 것(1.8mL×50cartridges) ㅇ용도 : 치과용 국소마취제Decided line: 3004909900Date: 2018-08-23Reference: CLIP-0072018003090
- KR관세평가분류원Medicaments; Nutriband Slimline patch; U.S.Aㅇ 클로로겐산, L-타우린, 라즈베리케톤, 녹차추출물 등으로 도포하고 이형지를 부착한 직사각형의 패치(25 X 75mm)를 알루미늄 증착 팩에 개별 포장한 것 - 용도 : 피부에 부착하여 식욕억제 및 다이어트 효과를 줌Decided line: 3004909900Date: 2018-06-21Reference: CLIP-0072018002940
- KR관세평가분류원Collagen Preparation; COLTRIX CartiRegen돼지 추출 콜라겐, 이염기인산나트륨, 염화나트륨, 콜라겐용해액 등으로 조제된 물품이 플라스틱 주사기에 삽입 밀봉되었고, 주입 할 수 있는 주사바늘이 세트 포장되어 살균 및 밀봉된 소매용 완제품임(내용량 3% collagen 1cc 주사기 x 2EA/set) - 용도 : 연골, 뼈 보충에 사용 ※ 품목분류는 수...Decided line: 3004909900Date: 2018-05-16Reference: CLIP-0072018002319
Sources: Ministry of Finance: frequent importers and the low-value exemption · Customs Administration: how customs collects business tax on imported goods · Customs Administration: taxes and fees payable on imported goods · Customs Administration: which mainland Chinese goods are permitted · Taipei Customs: notes on simplified declaration for imported express consignments · Ministry of Finance regulations database: rules for simplified clearance of air express consignments · International Trade Administration: special rules for importing mainland Chinese goods · TFDA: cosmetic product listing · MOF law system: Regulations Governing the Inspection, Taxation and Release of Inbound Passengers' Baggage (art. 11 allowances) · Customs Administration: real-name verification for express consignees (EZ WAY) · International Trade Administration: rules governing imports of mainland goods (MW0 and MP1 definitions) · International Trade Administration: trade promotion service fee (rate and basis) · Laws and Regulations Database of Taiwan: Customs Act article 16 (import declaration deadline) · Laws and Regulations Database of Taiwan: Customs Import Tariff, General Rules (which of the three rate columns applies) · Census Bureau: Foreign Trade Regulations frequently asked questions · eCFR: 15 CFR part 30, Foreign Trade Regulations · CBP: Automated Export System (AES) · International Trade Administration: Electronic Export Information (EEI) · Bureau of Industry and Security: Export Administration Regulations · Census Bureau: Schedule B search engine · eCFR: 15 CFR 30.4 — Electronic Export Information filing procedures and deadlines by mode · eCFR: 15 CFR 30.10 — retention of export information (five years)
I am a: Customs broker — Changes which blocks are emphasised